Abstract
The prognosis for blastic natural killer (NK) cell lymphoma is generally dismal. We report a patient who was successfully treated with unrelated cord blood transplantation (UCBT). A 15-year-old boy was diagnosed as having blastic NK cell lymphoma in the cervical lymph nodes. Autologous peripheral blood stem cell transplantation was performed on achieving a complete remission. However, the disease recurred in the bone marrow 6 months later. Chemotherapy induced a second remission and the patient received UCBT with a conditioning regimen consisting of total body irradiation, thiotepa and cyclophosphamide. Chronic GVHD of the lung occurred, but it was well controlled with steroids. At the time of writing, he remains in remission 18 months after UCBT with an excellent performance status. UCBT may be an option for patients with blastic NK cell lymphoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Loughran TP Jr . Clonal disease of large granular lymphocytes Blood 1993 82: 1 14
Suzuki R, Yamamoto K, Seto M et al. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity Blood 1997 90: 2417 2428
Nakamura S, Suchi T, Koshikawa T et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract Am J Surg Pathol 1995 19: 284 296
Kobayashi Y, Nakamura S, Sasajima Y et al. Inconsistent association of Epstein–Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract Histopathology 1996 28: 111 120
Suzuki R, Nakamura S . Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia Leuk Res 1999 23: 615 624
Koita H, Suzumiya J, Ohshima K et al. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity Am J Surg Pathol 1997 21: 242 248
DiGiuseppe JA, Louie DC, Williams JE et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study Am J Surg Pathol 1997 21: 1223 1230
Drenou B, Lamy T, Amiot L et al. CD3-CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance Blood 1997 89: 2966 2974
Ko YH, Kim SH, Ree HJ . Blastic NK-cell lymphoma expressing terminal deoxynucleotidyl transferase with Homer-wright type pseudorosettes formation Histopathology 1998 33: 547 553
Mukai H, Kojima H, Suzukawa K . High-dose chemotherapy with peripheral blood stem cell rescue in blastoid natural killer cell lymphoma Leuk Lymphoma 1999 32: 583 588
Matano S, Nakamura S, Nakamura S et al. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein–Barr virus association Acta Haematol 1999 101: 206 208
Nagatani T, Okazawa H, Kambara T et al. Cutaneous monomorphous CD4- and CD56-positive large-cell lymphoma Dermatology 2000 200: 202 208
Gloeckner-Hofmann K, Ottesen K, Schmidt S et al. T-cell/natural killer cell lymphoblastic lymphoma with an unusual coexpression of B-cell antigens Ann Hematol 2000 79: 635 639
Kimura S, Kakazu N, Kuroda J et al. Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma Ann Hematol 2001 80: 228 231
Isobe K, Tamaru J, Nakamura S et al. Blastic natural killer cell lymphoma arising from the mediastinum with terminal deoxynucleotidyl transferase expression Pathol Int 2001 51: 55 59
Rakozy CK, Mohamed AN, Vo TD et al. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse Am J Clin Pathol 2001 116: 168 176
Bayerl MG, Rakozy CK, Mohamed AN et al. Blastic natural killer cell lymphoma/leukemia. A report of seven cases Am J Clin Pathol 2002 117: 41 50
Chan JKC, Jaffe ES, Ralfkiaer E . Blastic NK-cell lymphoma In: Jaffe ES, Harris NL, Stein H, Valdiman JW (eds) Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues IARC Press: Lyon 2001 pp 214 215
Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients New Engl J Med 1996 335: 157 166
Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors New Engl J Med 1997 337: 373 381
Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors New Engl J Med 1998 339: 1565 1577
Locatelli F, Rocha V, Chastang C et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia Blood 1999 93: 3662 3671
Ooi J, Iseki T, Nagayama H et al. Unrelated cord blood transplantation for adult patients with myelodysplastic syndrome-related secondary acute myeloid leukaemia Br J Haematol 2001 114: 834 836
Acknowledgements
We thank K Oshimi MD and K Ohnuma for valuable suggestions, Y Zaike for photography and D Mrozek for correction of English.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshimasu, T., Manabe, A., Tanaka, R. et al. Successful treatment of relapsed blastic natural killer cell lymphoma with unrelated cord blood transplantation. Bone Marrow Transplant 30, 41–44 (2002). https://doi.org/10.1038/sj.bmt.1703597
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703597
Keywords
This article is cited by
-
Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms
Bone Marrow Transplantation (2006)
-
Long-term remission in a patient with hepatosplenic γδ T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation
Bone Marrow Transplantation (2006)
-
Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein–Barr virus (CAEBV) infection with allogeneic bone marrow transplantation
Bone Marrow Transplantation (2003)